This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The type 1 diabetes (T1D) market across the seven major markets (7MM*) is set to grow at a compound annual growth rate (CAGR) of 13.3 The type 1 diabetes (T1D) market across the seven major markets (7MM*) is set to grow at a compound annual growth rate (CAGR) of 13.3 per cent from $2.2 billion in 2023 to $9.9 per cent from $2.2
In a global first, some travelers and laboratory researchers who are at risk of contracting chikungunya will soon be allowed to be vaccinated against the virus. A committee of vaccine experts recommended Wednesday that those selective groups of people should be offered access to the new vaccine, Ixchiq, which is made by Valneva Austria GmbH.
Eli Lilly’s third-quarter sales and earnings were lower than expected, a rare stumble for the company that had consistently reported strong sales and beat earnings forecasts since demand for its blockbuster weight loss and diabetes drugs began booming, STAT says. The diabetes treatment Mounjaro brought in $3.1 billion and $1.7
The Food and Drug Administration approved a Pfizer vaccine that aims to protect newborns against RSV by vaccinating pregnant people, STAT tells us. The vaccine, marketed as Abrysvo, previously won approval for adults over the age of 60. Continue to STAT+ to read the full story…
Once the domain of aging TV stars, hawking health products from vitamins to diabetes supplies to a geriatric demographic, A-list celebrity endorsements of health care products are positively trendy. Migraine sufferer Lady Gaga has a deal with Nurtec ODT , a prescription drug that treats migraines from pharma company Pfizer.
The document says that public funding for the development of vaccines and treatments should be more transparent, and include provisions to ensure that any resulting products are distributed evenly around the world. The first therapy that delays the onset of type 1 diabetes received approval from the U.S. As of 2019, about 1.9
We accept all manner of confidential communications and secret dossiers … New diabetes and weight loss drugs may benefit patients undergoing hip replacement without adding to complication risks , Reuters reports, citing preliminary data released at a meeting of orthopedic surgeons.
For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of pharmaceutical companies that make insulin, vaccines, and more before the panel with progressively more ambitious demands related to their pricing. Sanders (I-Vt.)
… Novo Nordisk is leaving nothing to chance when it comes to claiming a stake in the burgeoning market for diabetes and obesity therapies, announcing a plan to spend a whopping $6 billion to expand its manufacturing capacity , Pharmaphorum tells us. The Well, whatever you do, have a grand time. But be safe.
… With new vaccine data released on Tuesday, Vaxcyte emerged as one of biotechnology’s hottest David-vs.-Goliath Goliath stories as the company seeks to challenge one of Pfizer’s biggest franchises: the Prevnar vaccine against pneumococcal disease , STAT tells us.
Top of the morning to you. The middle of the week is upon us and, since you made it this far, why not forge ahead? After all, there is always light at the end of the proverbial tunnel. You never know what you may accomplish. So please join us as we celebrate this notion with a cup or three of delicious stimulation.
They include things such as controlling blood sugar for people with diabetes, ensuring that eligible adults are screened for colon and breast cancer, and guaranteeing that children are up to date on their vaccines and are receiving topical fluoride treatments.
Food and Drug Administration for a “reckless and arbitrary” decision to remove a widely prescribed Eli Lilly drug for combating diabetes and obesity from an official shortages list , STAT tells us. A group of doctors and medical practices claimed they overpaid for the vaccine, which was the only mumps shot in the U.S.
Up to one in 20 new cases of diabetes could be linked to Covid infection, a large study has concluded. But people who were vaccinated against Covid did not have a higher risk of diabetes.
November is American Diabetes Month – a time to come together to spread awareness about diabetes prevention and management. In this blog post, we’ll explore key ways pharmacies can actively participate in American Diabetes Month.
People exposed to higher levels of air pollution before the pandemic had lower antibody responses to COVID-19 vaccines, according to a study. Air pollutants have been shown to affect immune responses, so in this study we wished to determine whether air pollution also affects antibody responses to COVID-19 vaccines,” said Kogevinas.
Messenger ribonucleic acid (mRNA)-based innovator pharmaceuticals saw a staggering 800 per cent increase in licensing agreement deal values from 2019 to 2024YTD, driven by the remarkable success of mRNA vaccines during the COVID-19 pandemic. billion in 2030. Bristol Myers Squibb formed a multi-year, $1.87
The World Health Organisation (WHO) has revised its recommendations regarding the use of Covid-19 vaccines following a meeting of the agency’s Strategic Advisory Group of Experts on Immunisation (SAGE). The panel emphasised that the extra booster dose recommendation only pertains to one shot and is not for continued annual booster vaccines.
Hospitalization and interprofessional team management, particularly the involvement of a pharmacist, are essential in vaccination coverage for patients with diabetes.
Moderna is close to completing its phase 3 trial of COVID-19 vaccine candidate mRNA-1273 after completing recruitment of the 30,000 subjects in the trial. Like Pfizer/BioNTech and other coronavirus vaccine developers, Moderna has committed to ensuring that it has full safety and efficacy data available before filing for an EUA.
GlaxoSmithKline Pharmaceuticals (GSK) announced the launch of Shingrix (Zoster Vaccine Recombinant, Adjuvanted) in India, for the prevention of shingles (herpes zoster) and post-herpetic neuralgia in adults aged 50 years and above. Shingrix is a non-live, recombinant subunit vaccine to be given intramuscularly in two doses.
The survey shows that although 71 per cent of adults aged ≥50 years are aware of adult vaccination, only 16 per cent have taken any adult vaccines. A majority of doctors surveyed (90 per cent) state that a lack of formal guidelines results in a lack of interest and adoption of vaccination by patients.
GSK announced that the US Food and Drug Administration (FDA) has approved Arexvy (respiratory syncytial virus vaccine, adjuvanted) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. per cent (96.95% CI, 57.9–94.1, per cent (95% CI, 62.4–99.9,
Eli Lilly’s decision to throw large amounts of research dollars at its next-generation diabetes drug tirzepatide could be vindicated, according to its first phase 3 trial readout. More than half (51.7%) of participants in the treatment arm achieved an A1C less than 5.7% – the level seen in people without diabetes.
The business comprises more than 400 APIs used in drugs to treat everything from migraines to diabetes, and employs over 5,000 staff. agency and Colombian authorities of problems at the Caucaseco Scientific Research Center and the Malaria Vaccine Development Center.
After a period where vaccine development had fallen away, suddenly it is back in the limelight. However, for those individuals working on vaccine development, the pandemic has proven to be a validation of the important work being carried out in the field. billion from its vaccine in 2021. The ‘poor relation’.
GSK announced that the US FDA has approved Arexvy (Respiratory Syncytial Virus (RSV) Vaccine, Adjuvanted) for the prevention of RSV lower respiratory tract disease (LRTD) in adults 50 to 59 years of age who are at increased risk. RSV can exacerbate these conditions and lead to pneumonia, hospitalisation or death.(4)
They serve as accessible hubs for health advice, chronic disease management, vaccinations, and more. Such disruptions can lead to more frequent hospital admissions, particularly for individuals managing chronic conditions like diabetes, asthma, or epilepsy.
Vaccination Services With the increased awareness around public health and the importance of vaccinations, many clients are searching for pharmacies that offer vaccination services. Common queries include “flu jab near me,” “COVID-19 vaccine booking,” or “travel vaccines at pharmacies.”
A thyroid cancer safety signal was raised by the European Medicines Agency last month over several Novo Nordisk drugs, including semaglutide, which is used in popular diabetes and obesity drugs Ozempic and Wegovy , Reuters notes. The
Luckily, two new RSV vaccines have been developed and approved to help combat this risk and will be available this fall. If you are concerned about your vulnerability to RSV and are over the age of 60, then you can book a time slot immediately to receive the vaccine at your nearest Community Pharmacy location. What is RSV?
Moderna shares have fallen 29% so far this year and are down more than 82% from their highs during the pandemic — when its ability to rapidly develop a Covid-19 vaccine stood as a proof-of-concept for its technology and left it flush with revenue. The stock was trading 3.5%
Her current primary accounts are Jardiance, REGEN-COV, Rexulti, and BD Global Diabetes Care. Antoinette’s therapeutic area experience includes oncology, infectious diseases, CNS, immunology, cardiovascular health, diabetes, wound and skin care, adult vaccines, and medical devices.
This will help support launch of future biologics and vaccines, as well as the continued growth of Dupixent ® ; which could become the first biologic to treat chronic obstructive pulmonary disease (COPD), according to Sanofi. An investment of €250 million will used to build Europe’s largest flu vaccine production unit in Val de Reuil.
billion in sales from its COVID-19 vaccine Vaxzevria in the first half of this year, but making it available at no profit had weighed on its profit margins. billion from its one-dose vaccine. AstraZeneca said this morning that it has made $1.2 Earlier this week, Pfizer reported that it had made $7.8 billion and $1.13
Moderna looks odds on to claim emergency use authorisation from the FDA for its COVID-19 vaccine this week, after the regulator published a report endorsing its safety and rating its efficacy at 94.5%. Both vaccines will be provided free of charge to recipients.
AstraZeneca has said it plans to start making a small profit from sales of its COVID-19 vaccine Vaxzevria, which brought in just over $1 billion in sales in the third quarter, after selling it at cost since it was first made available. The post AstraZeneca will make ‘modest’ profit from COVID vaccine appeared first on.
This is an ongoing challenge, and one that reared its head again during the pandemic, as questions over vaccine equity arose. Partha Kar, national specialty advisor on diabetes with NHS England, recently gave a presentation at the annual meeting of the European Association for the Study of Diabetes 2022 that centred on access.
From cancer prevention to diabetes awareness, these events help bring communities together. National Diabetes Month. National Influenza Vaccination Week: December 6-12. Cervical Health Awareness Month | S hare downloadable content from the NCCC and advocate for HPV vaccinations. Healthy Lung Month. Health Literacy Month.
For example, a pharmaceutical company that develops a new drug for diabetes could sponsor a community walkathon to raise awareness about the disease and promote healthy living. For example, a pharmaceutical company that develops a new vaccine could donate vaccines to local schools to help protect children from preventable diseases.
The medicines – which include insulin, oral diabetes agent glibenclamide and cancer chemotherapy oxaliplatin – will be sold under a new Impact brand and are all classed as essential medicines by the World Health Organisation (WHO). ” The post Sanofi makes low-cost medicines pledge for low-income countries appeared first on.
AstraZeneca confirmed today that it has discontinued clinical development of a follow-up to its COVID-19 vaccine Vaxzevria targeted at the Beta variant of the virus, which started development before the emergence of the Delta and Omicron strains. The post AZ halts development of Beta variant COVID-19 vaccine appeared first on.
Take for example Type I Diabetes (sometimes called Juvenile Diabetes). Second, It helps me better explain why insulin is the bulwark of treatment in these patients compared to Type II Diabetes. Insulin has been around for less than a century, but diabetes has been around our entire species timeframe.
The €156 million initiative identifies effective actions and the available legal and financial supporting tools across five main areas: cardiovascular diseases, diabetes, chronic respiratory diseases, mental health and neurological disorders, as well as their main contributing factors.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content